267 related articles for article (PubMed ID: 34095712)
21. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract][Full Text] [Related]
22. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
[TBL] [Abstract][Full Text] [Related]
23. Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience.
Pondrom M; Bougeard G; Karanian M; Bonneau-Lagacherie J; Boulanger C; Boutroux H; Briandet C; Chevreau C; Corradini N; Coze C; Defachelles AS; Galmiche-Roland L; Orbach D; Piguet C; Scoazec JY; Vérité C; Willems M; Frebourg T; Minard V; Brugières L
Pediatr Blood Cancer; 2020 Sep; 67(9):e28486. PubMed ID: 32658383
[TBL] [Abstract][Full Text] [Related]
24. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
[TBL] [Abstract][Full Text] [Related]
25. Survey of germline variants in cancer-associated genes in young adults with colorectal cancer.
Mikaeel RR; Young JP; Li Y; Smith E; Horsnell M; Uylaki W; Tapia Rico G; Poplawski NK; Hardingham JE; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Price TJ
Genes Chromosomes Cancer; 2022 Feb; 61(2):105-113. PubMed ID: 34761457
[TBL] [Abstract][Full Text] [Related]
26. Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes.
Gillani R; Camp SY; Han S; Jones JK; Chu H; O'Brien S; Young EL; Hayes L; Mitchell G; Fowler T; Gusev A; Kamihara J; Janeway KA; Schiffman JD; Crompton BD; AlDubayan SH; Van Allen EM
Am J Hum Genet; 2022 Jun; 109(6):1026-1037. PubMed ID: 35512711
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Kim J; Luo W; Wang M; Wegman-Ostrosky T; Frone MN; Johnston JJ; Nickerson ML; Rotunno M; Li SA; Achatz MI; Brodie SA; Dean M; de Andrade KC; Fortes FP; Gianferante M; Khincha P; McMaster ML; McReynolds LJ; Pemov A; Pinheiro M; Santiago KM; Alter BP; Caporaso NE; Gadalla SM; Goldin LR; Greene MH; Loud J; Yang XR; Freedman ND; Gapstur SM; Gaudet MM; Calista D; Ghiorzo P; Fargnoli MC; Nagore E; Peris K; Puig S; Landi MT; Hicks B; Zhu B; Liu J; Sampson JN; Chanock SJ; Mirabello LJ; Morton LM; Biesecker LG; Tucker MA; Savage SA; Goldstein AM; Stewart DR
Genome Med; 2018 Dec; 10(1):99. PubMed ID: 30583724
[TBL] [Abstract][Full Text] [Related]
28. The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility.
Liu M; Liu X; Suo P; Gong Y; Qu B; Peng X; Xiao W; Li Y; Chen Y; Zeng Z; Lu Y; Huang T; Zhao Y; Liu M; Li L; Chen Y; Zhou Y; Liu G; Yao J; Chen S; Song L
Transl Lung Cancer Res; 2020 Jun; 9(3):646-658. PubMed ID: 32676327
[TBL] [Abstract][Full Text] [Related]
29. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.
Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG
Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458
[TBL] [Abstract][Full Text] [Related]
30. Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options.
Tlemsani C; Leroy K; Gimenez-Roqueplo AP; Mansuet-Lupo A; Pasmant E; Larousserie F; Boudou-Rouquette P; Vidaud M; Cadranel J; Blons H; Goldwasser F; Laurent-Puig P
J Med Genet; 2020 Feb; 57(2):104-108. PubMed ID: 30352869
[TBL] [Abstract][Full Text] [Related]
31. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
Würtemberger J; Ripperger T; Vokuhl C; Bauer S; Teichert-von Lüttichau I; Wardelmann E; Niemeyer CM; Kratz CP; Schlegelberger B; Hettmer S
Eur J Med Genet; 2023 May; 66(5):104718. PubMed ID: 36764384
[TBL] [Abstract][Full Text] [Related]
32. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.
Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA
Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117
[TBL] [Abstract][Full Text] [Related]
33. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.
Mezina A; Philips N; Bogus Z; Erez N; Xiao R; Fan R; Olthoff KM; Reddy KR; Samadder NJ; Nielsen SM; Hatchell KE; Esplin ED; Rustgi AK; Katona BW; Hoteit MA; Nathanson KL; Wangensteen KJ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250406
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
[TBL] [Abstract][Full Text] [Related]
35. Germline pathogenic variants in 786 neuroblastoma patients.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
medRxiv; 2023 Jan; ():. PubMed ID: 36747619
[TBL] [Abstract][Full Text] [Related]
36. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
[TBL] [Abstract][Full Text] [Related]
37. Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer.
Bandeira G; Rocha K; Lazar M; Ezquina S; Yamamoto G; Varela M; Takahashi V; Aguena M; Gollop T; Zatz M; Passos-Bueno MR; Krepischi A; Okamoto OK
Breast Cancer; 2021 Mar; 28(2):346-354. PubMed ID: 32986223
[TBL] [Abstract][Full Text] [Related]
38. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.
Zin A; Bertorelle R; Dall'Igna P; Manzitti C; Gambini C; Bisogno G; Rosolen A; Alaggio R
Am J Surg Pathol; 2014 Feb; 38(2):273-8. PubMed ID: 24418861
[TBL] [Abstract][Full Text] [Related]
39. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.
; Mavaddat N; Dorling L; Carvalho S; Allen J; González-Neira A; Keeman R; Bolla MK; Dennis J; Wang Q; Ahearn TU; Andrulis IL; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Briceno I; Brüning T; Camp NJ; Campbell A; Castelao JE; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Christiansen H; Czene K; Dörk T; Eriksson M; Evans DG; Fasching PA; Figueroa JD; Flyger H; Gabrielson M; Gago-Dominguez M; Geisler J; Giles GG; Guénel P; Hadjisavvas A; Hahnen E; Hall P; Hamann U; Hartikainen JM; Hartman M; Hoppe R; Howell A; Jakubowska A; Jung A; Khusnutdinova EK; Kristensen VN; Li J; Lim SH; Lindblom A; Loizidou MA; Lophatananon A; Lubinski J; Madsen MJ; Mannermaa A; Manoochehri M; Margolin S; Mavroudis D; Milne RL; Mohd Taib NA; Morra A; Muir K; Obi N; Osorio A; Park-Simon TW; Peterlongo P; Radice P; Saloustros E; Sawyer EJ; Schmutzler RK; Shah M; Sim X; Southey MC; Thorne H; Tomlinson I; Torres D; Truong T; Yip CH; Spurdle AB; Vreeswijk MPG; Dunning AM; García-Closas M; Pharoah PDP; Kvist A; Muranen TA; Nevanlinna H; Teo SH; Devilee P; Schmidt MK; Easton DF
JAMA Oncol; 2022 Mar; 8(3):e216744. PubMed ID: 35084436
[TBL] [Abstract][Full Text] [Related]
40. Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.
Carlo MI; Ravichandran V; Srinavasan P; Bandlamudi C; Kemel Y; Ceyhan-Birsoy O; Mukherjee S; Mandelker D; Chaim J; Knezevic A; Rana S; Fnu Z; Breen K; Arnold AG; Khurram A; Tkachuk K; Cipolla CK; Regazzi A; Hakimi AA; Al-Ahmadie H; Dalbagni G; Cadoo KA; Walsh MF; Teo MY; Funt SA; Coleman JA; Bochner BH; Iyer G; Solit DB; Stadler ZK; Zhang L; Rosenberg JE; Taylor BS; Robson ME; Berger MF; Vijai J; Bajorin DF; Offit K
J Clin Oncol; 2020 Feb; 38(5):406-414. PubMed ID: 31794323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
